Results 31 to 40 of about 2,254,446 (272)

Knowing what we count : a comment on Guo [PDF]

open access: yes, 2011
Guo (2011) points to problems arising from different approaches to estimating the proportions of floras that are native or alien, specifically those across and within various regions.
Pyšek, Petr
core   +2 more sources

Factor proportions and international business cycles [PDF]

open access: yes, 2011
Positive investment comovements across OECD economies as observed in the data are difficult to replicate in open-economy real business cycle models, but also vary substantially in degree for individual country-pairs.
Jin, Keyu, Li, Nan
core  

Stressful Events Reported by Childhood Cancer Survivors and Community Controls From the St. Jude Lifetime (SJLIFE) Cohort: A Mixed Method Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Characterizing stressful events reported by childhood cancer survivors experienced throughout the lifespan may help improve trauma‐informed care relevant to the survivor experience. Methods Participants included 2552 survivors (54% female; 34 years of age) and 469 community controls (62% female; 33 years of age) from the St.
Megan E. Ware   +13 more
wiley   +1 more source

Exploring the effectiveness of developing preservice teachers’ knowledge of primary mathematics curriculum through professional placement experiences

open access: yesCogent Education
Knowledge of curriculum (KOC) is an important aspect of pedagogical content knowledge (PCK) for mathematics teaching that helps ensure effective teaching and benefits learning.
Xiaowen Ma, Robin Averill, Linda Bonne
doaj   +1 more source

Proportions of r-regular elements in finite classical groups

open access: yes, 2012
For a prime $r$, we obtain lower bounds on the proportion of $r$-regular elements in classical groups and show that these lower bounds are the best possible lower bounds that do not depend on the order of the defining field.
Babai, Laszlo   +3 more
core   +2 more sources

Carcinomas and Carcinoid Tumors of the Lungs and Bronchi in Children and Adolescents: The EXPeRT Recommendations

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Primary lung carcinomas and bronchial carcinoid tumors (BC) are very rare malignancies in childhood. While typical BC and mucoepidermoid carcinomas are mostly low‐grade, localized tumors with a more favorable prognosis than in adults, necessitating avoidance of overtreatment, adenocarcinomas of the lung are often diagnosed at advanced disease ...
Michael Abele   +19 more
wiley   +1 more source

Factor Proportions and the Growth of World Trade [PDF]

open access: yes, 2012
Most of the expansion of global trade during the last three decades has been of the North-South kind - between capital-abundant developed and labour-abundant developing countries.
Zymek, Robert
core   +2 more sources

Results of the Childhood Cancer and Leukaemia Group's United Kingdom Relapsed Wilms Tumour Trial

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background The United Kingdom relapsed Wilms tumour (UKW‐R) trial aimed to improve the historically low survival rates after relapse of Wilms tumour (WT) through a prospective national risk‐stratified protocol. The trial also evaluated efficacy and toxicity of high‐dose melphalan.
Sucheta J. Vaidya   +10 more
wiley   +1 more source

Co-training for Demographic Classification Using Deep Learning from Label Proportions

open access: yes, 2017
Deep learning algorithms have recently produced state-of-the-art accuracy in many classification tasks, but this success is typically dependent on access to many annotated training examples.
Ardehaly, Ehsan Mohammady, Culotta, Aron
core   +1 more source

Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High‐Risk Neuroblastoma: A Multi‐Institutional Retrospective Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Chemoimmunotherapy with irinotecan, temozolomide, and dinutuximab (I/T/DIN) has emerged as first‐line therapy for relapsed/refractory (r/r) high‐risk neuroblastoma (HRNB) in North America. Topotecan and cyclophosphamide (T/C) are often used in combination with dinutuximab in the setting of lack of response, progression, or incomplete ...
Benjamin J. Lerman   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy